CASR and idiopathic pulmonary fibrosis: Exogenous treatment of NHLFs and IPF HLFs with TGFβ1 induced ornithine secretion; CaSR NAM co-treatment reduced ornithine secretion in IPF fibroblasts by 65% (p = 0.0003) (Figure 7A,B).